Aruni Ghose: Closing the gap in Cervical Cancer

Aruni Ghose posted on LinkedIn:

“As the London Global Cancer Week beckons 11th – 15th November 2024 . . .
Hot off the UKI Global Cancer Network firm – pleasure to produce this with Katie Wakeham, Susie Stanway, Bhawna Sirohi. Julie S. Torode with the Support of our friends at ecancer – Danny Burke, Enrique Grande, Mary Guevara Salas

Our Message (CLOSE THE CANCER CARE GAP) is Loud and Clear = ‘The dramatic disparity in Cervical Cancer incidence rates between HICs and LMICs is primarily due to differential access to effective screening and preventive treatment; similar disparities also exist within countries. As HPV vaccinations are practically feasible and cost-effective, increasing acceptance and coverage should be a public health priority. While the context-specific barriers should be addressed, there is a clear need for regular monitoring and sustained funding within all HIC and LMIC settings to ensure progress is sustained. The efficacy of single-dose schedules has the potential to accelerate progress considerably in the coming years; they will massively enhance cost-effectiveness, simplify delivery schedules and enhance coverage. On another note, HPV testing for primary screening dominates other strategies (i.e., it is more effective and cost effective) and, therefore, if implemented properly with regular testing and stringent quality assurance checks, it could become a well-rounded and universal option with cost-effectiveness and optimum therapeutic value for LMICs and HICs alike. However, vaccines should not substitute screening and vice-versa – a combined approach is needed to combat this global problem. It is undoubtedly the need of the hour as international gaps are threatened to widen secondary to the lag in LMICs.’

CLOSE THE CANCER CARE GAP is the Dream I started with Maryam Hasanova in OncoFlow.”

Source: Aruni Ghose/LinkedIn

Aruni Ghose, an Internal Medicine Resident at Barts Health NHS Trust.  He is the Chief Medical Officer of OncoFlow.

 Additionally, he serves as a Focused Topic Network Member at the European Cancer Organisation and sits on the Editorial Board at BMC. His research focuses on Genitourinary Cancer, Immuno Oncology, Global Oncology, Cardio Oncology, and Lung Cancer.